Alpha 2.0
Login Register
» Articles » PMID: 36473739

[Expertise for Management of Immune-related Adverse Events in Cancer Therapy]

Overview
Journal Bull Cancer
Publisher Elsevier
Specialty Oncology
Date 2022 Dec 6
PMID 36473739
Authors
Mathias Thomas
Amelie Rognon
Thomas Escoda
Chloe Stavris
Laurent Chiche
Affiliations
Soon will be listed here.
Citing Articles

Risk of Serious Immune-Related Adverse Events with Various PD1 and PD-L1 Inhibitors: A Single-Institution, Real-Life, Comparative Study.

Boucheron T, Chiche L, Penaranda G, Souquet M, Pegliasco H, Deturmeny J Ther Clin Risk Manag. 2025; 21:273-282.

PMID: 40060169 PMC: 11890422. DOI: 10.2147/TCRM.S479686.